GL1X · GenesisL1 explorer

MolNFT v1 · #141155 · protein

Co-crystal structure of KRAS (G12C) covalently bound with quinazoline based inhibitor JBI739

5YY1 · GTPase KRAS: “Co-crystal structure of KRAS (G12C) covalently bound with quinazoline based inhibitor JBI739”. X-ray diffraction, 3 ligands (GDP, 94F, MG), 1 pocket (best druggability 0.69). MolNFT v1 #141155 on GenesisL1: 3D…

PDB
5YY1
Type
protein
Length
170 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
GTPase KRAS
UniProt
P01116
Ligands
GDP, 94F, MG
Pockets
1 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGTPase KRASprotein17037% helix, 25% strandP01116

Ligands and binding sites

  • GDP · Guanosine-5'-diphosphate · ligand · chains A
  • 94F · 1-[4-[6-chloranyl-8-fluoranyl-7-[2-(trifluoromethyl) phenyl]quinazolin-4-yl]piperazin-1-yl]propan-1-one · ligand · chains A
  • MG · Magnesium ion · metal · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12920.690.8346MG, GDP, 94F, EDO

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 5YY1 · Co-crystal Structure of KRAS (G12C) covalently bound with Quinazoline based inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.